Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 78.62M 29.24B | Sales 2023 | 322M 86.48M 32.17B | Capitalization | 169M 45.36M 16.87B |
---|---|---|---|---|---|
Net income 2022 | -2M -538K -200M | Net income 2023 | -6M -1.61M -600M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 39.1M 14.54B | Net Debt 2023 | 166M 44.75M 16.64B | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
+14.53% | 69.68B | |
+7.11% | 8.21B | |
-20.55% | 7.96B | |
-4.06% | 7.75B | |
+1.95% | 4.64B | |
+17.12% | 4.32B | |
-1.24% | 4.09B | |
-3.37% | 3.82B | |
+21.42% | 3.62B |